Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial
CDK2/9抑制剂Fadraciclib联合化疗治疗晚期恶性肿瘤患儿的I/II期研究：AcSé-ESMART试验的K组
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01208-1
Rubio-San-Simón, Alba; Marshall, Lynley V; Karamouza, Eleni; André, Nicolas; Abbou, Samuel; Rubino, Jonathan; Nebchi, Souad; Aerts, Isabelle; Thebaud, Estelle; Brisset, Claire; Ducassou, Stephane; Le Teuff, Gwénaël; Geoerger, Birgit
